In the field of medicine in Taiwan, precision medicine has become a rising star of medical technology development. The Tri-Service General Hospital Center for Precision Medicine and Genomics, as the pioneer in the field, has successfully accumulated a series of amazing results over the past six years.

ISO 15189 certificate: Commitment to quality

The Genomics Center is firmly on the road of precision medicine and has achieved international medical laboratory ISO 15189 certification through an onsite inspection as recognition of the overall medical quality of the hospital. Moreover, it confirms of our cautious attitude toward precision medicine studies. By establishing such a high standard of quality control for genetic medical test accuracy, each study and diagnosis will be highly accurate and reliable.

Special Formosa 3D report filmed by Golden Bell awarded director: Glory of imaging power

The Genomics Center has gathered all domestic and international medical and top technology power of genetic testing, so the studies and achievements of the center are highly recognized as well. Even more, the Genomics Center has attracted a Golden Bell award -winning director to produce a special report. The outstanding achievements of Taiwan in the field of precision medicine are delicately illustrated in the film, marking not only a significant scientific event, but also a proud moment for Taiwan in the international spotlight of medicine.

Assisting the Nephrology Department with NHQA onsite visits and earning a Golden Award: The power of caring

The Genomics Center is not only dedicated to precision medicine studies, but also strongly involved in community services. While assisting the Nephrology Department with NHQA onsite visits, the Genomics Center provided excellent support and assistance and won the 24th NHQA Golden Award in 2023. This recognition highlights the professional capabilities of the Center and proof of the enthusiasm for patient care and involvement in society.

Developing the first MODY diabetes genetic chip in Taiwan: The power of innovation

In the era of rapidly developing technology, the Genomics Center has pioneered the development of the first breakthrough MODY diabetes gene chip in Taiwan – a new cutting edge advancement in precision medicine. This innovation has not only enhanced the accuracy of the diabetes treatment, but also positioned Taiwan prominently on the international stage of genome study applications in metabolic disease testing, diagnosis, and research.

Reflecting on the experiences and progress of the past six years, the Tri-Service General Hospital Center for Precision Medicine and Genomics has not only actively pursued research and studies, but also continued to make significant strides in clinical implementation and community services. Their achievements not only showcase Taiwan’s outstanding performance in the field of precision medicine, but also exemplify the noble mission ` of humanizing medicine. In the future, we anticipate the team will continue to explore opportunities and set new records in the field of precision medicine.